Calvin Johnson

Dr. Calvin B. Johnson, MD, is a Chief Medical Officer at Royal Caribbean Group, a Director at PLSG Capital Investment Programs and an Independent Director at Ibere Pharmaceuticals. He is on the Board of Directors at Highmark, Inc., National Initiative for Childrens Health Care Quality, Inc. and Ibere Pharmaceuticals. Dr. Johnson was previously employed as a Chief Medical Officer by Corizon Health, Inc., a Chief Medical Officer & Executive Vice President by MinSec Cos. LLC, a President by Altre Strategic Solutions Group LLC, an Assistant Professor by Temple University (Pennsylvania), and a Principal by Temple University Health System, Inc. He also served on the board at The Biotechnology Greenhouse Corp. of Southeastern PA. He received his undergraduate degree from Morehouse College, a graduate degree from Johns Hopkins Bloomberg School of Public Health and a doctorate degree from The Johns Hopkins University School of Medicine.